ONCONOX APS has a total of 19 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are BIOGROWTH INC, DONG ZHENG XIN and ARAIM PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Hong Kong | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nicoletti Ferdinando | 12 |
#2 | Meroni Pier Luigi | 4 |
#3 | Sblattero Daniele | 4 |
#4 | Tedesco Francesco | 4 |
#5 | Al-Abed Yousef | 2 |
#6 | Garotta Gianni | 2 |
#7 | Nicoletti Ferninando | 1 |
#8 | Ferdinando Nicoletti | 1 |
Publication | Filing date | Title |
---|---|---|
EP3019525A1 | Antibodies to beta2-glycoprotein i and therapeutic uses thereof | |
AU2013349804A1 | Saquinavir-no for immunomodulation | |
EP2306995A1 | Antitumor properties of no modified protease inhibitors | |
AU2008250676A1 | (S,R)-3-Phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agent | |
EP1863480A1 | Compounds having immunomodulator activity |